Abstract:Hyperglycemia during type 1 Diabetes (T1D) is driven not only by a lack of insulin secretion due to autoimmune destruction of the pancreatic β-cells, but also by hypersecretion of glucagon from pancreatic α-cells. Insulin therapy can replace the lack of insulin secretion, but there is no effective therapeutic tool to counter the hyperglucagonemia. Brown adipose tissue (BAT) has gained attention for treating metabolic diseases due to its role as an endocrine organ and its effect on whole-body energy metabolism. Subcutaneous transplantation of embryonic BAT into T1D mouse models reverses hyperglycemia, independent of insulin but accompanied by reduced plasma glucagon levels, which suggests that lowering plasma glucagon plays a central role in restoring euglycemia. However, the molecular mechanism(s) underlying this action remain unclear. Towards discovering these mechanisms, we have examined the effects of secretions from immortalized brown adipocytes (imBAT) on pancreatic α-cells and mouse models of T1D. We show that the large molecule fraction (>100kDa) of imBAT-secreted factors suppresses glucagon secretion from both mouse and human pancreatic α-cells. Live cell fluorescence imaging shows that this fraction inhibits both intracellular Ca2+ and cAMP activities, and these inhibitions are ameliorated by blocking the insulin receptor, suggesting that imBAT-secreted factors act, at least in part, through these receptors. Injecting this imBAT-secreted fraction into the NOD mouse model reverses hyperglycemia (242 ± 47.4 to 146 ± 24.7mg/dL, n=8), suppresses hyperglucagonemia (77.6 ± 55.4 to 10.7 ± 4.75pg/mL, n=8), improves glucose tolerance (n=3), and increases thermogenic activity and differentiation of endogenous BAT (n=7). Our data provide insights into the mechanisms of long-term recovery of euglycemia by BAT transplants, and further fractionation experiments to isolate active factors are ongoing. Disclosure J.Lee: None. D.W.Piston: None. Funding The Leona M. and Harry B. Helmsley Charitable Trust (2305-06050); National Institutes of Health (R01DK123301, P30DK020579)

Single-Cell Landscape and a Macrophage Subset Enhancing Brown Adipocyte Function in Diabetes

Identification and Characterization of Distinct Murine Brown Adipocyte Lineages

Lipid-associated macrophages reshape BAT cell identity in obesity

Identification and characterization of distinct brown adipocyte subtypes in C57BL/6J mice

Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus

Generation of Mega Brown Adipose Tissue in Adults by Controlling Brown Adipocyte Differentiation in Vivo

BAF60a Deficiency in Macrophage Promotes Diet-Induced Obesity and Metabolic Inflammation

Single-nucleus RNA sequencing reveals cellular and molecular dynamics of white and brown adipose tissue in a mouse model of type-2 diabetes

Factors Associated with White Fat Browning: New Regulators of Lipid Metabolism

The Role of Brown Adipose Tissue Dysfunction in the Development of Cardiovascular Disease

A Chromatin Remodeling Checkpoint of Diet-Induced Macrophage Activation in Adipose Tissue

Activating Brown Adipose Tissue for Weight Loss and Lowering of Blood Glucose Levels: A MicroPET Study Using Obese and Diabetic Model Mice

Delivery of Adipose-Derived Stem Cells Attenuates Adipose Tissue Inflammation and Insulin Resistance in Obese Mice Through Remodeling Macrophage Phenotypes.

2046-LB: Selective, Acute Stimulation of Sympathetic Activity in Brown Adipose Tissue Improves Glycemic and Lipid Profiles in Mice

Brown adipose tissue prevents glucose intolerance and cardiac remodeling in high-fat-fed mice after a mild myocardial infarction

1653-P: Brown Adipocyte–Secreted Factors for Treating Type 1 Diabetes Mellitus

Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia

77-OR: Targeting JunB Induces a Shift from Low- to High-Thermogenic Adipocytes and Ameliorates Diet-Induced Insulin Resistance

Disease progression promotes changes in adipose tissue signatures in type 2 diabetic (db/db) mice: The potential pathophysiological role of batokines

Brown fat thermogenesis and branched-chain amino acids in metabolic disease